AACR-National Foundation for Cancer Research Professorship in Basic Cancer Research
Manuel Perucho, Ph.D., Director, Oncogene and Suppressor Gene Program, The Burnham Institute, La Jolla, Calif.
Dr. Manuel Perucho's laboratory studies the mechanisms underlying gastrointestinal cancer of the microsatellite mutator phenotype pathway.
The AACR and the National Foundation for Cancer Research (NFCR) established this Professorship in 2000 to honor Tamara and Franklin Salisbury, Sr., best known for founding the NFCR in 1973. It recognizes a senior scientist at the level of associate professor or professor who is currently engaged in an active research career anywhere in the world and who has demonstrated extraordinary achievement in basic cancer research. It is awarded every year to an individual nominated by his or her peers, who shows promise for continued substantive contributions to basic cancer research. The Professorship is intended to foster the research productivity of the recipient by enabling the scientist so honored to devote more time to basic research, through a one-year grant of $50,000.
AACR-Gertrude B. Elion Cancer Research Award
Yi Zhang, Ph.D., UNC-Chapel Hill School of Medicine & Lineberger Comprehensive Cancer Center
Role of the EZH2 Histone Methyltransferase Complex in Cancer
The AACR-Gertrude B. Elion Cancer Research Award was established in 1993 in honor of the late Nobel Laureate Dr. Gertrude B. Elion, Scientist Emeritus at Glaxo Wellcome Co. and Past President and Honorary Member of AACR. The Gertrude B. Elion Cancer Research Award fosters meritorious basic, clinical, or translational cancer research by a tenure-track scientist at the level of assistant professor. This is a one-year award, with a grant of $50,000.
Career Development Awards
AACR-PanCAN Career Development Award in Pancreatic Cancer Research
C. Max Schmidt, M.D., Ph.D., Indiana University School of Medicine, Indianapolis, Ind.
The Chemopreventative Role of Cyclooxygenase Inhibitors in Pancreatic Tumorigenesis
David A. Tuveson, M.D., Ph.D., University of Pennsylvania School of Medicine, Philadelphia, Pa.
Tumor Suppressor Gene Loss of Heterozygosity for the Generation of a Murine Model of Ductal Pancreatic Cancer
AACR-Cancer Research and Prevention Foundation Career Development Award in Translational Lung Cancer Research, in memory of R. Duffy Wall
Gabriela Chiosis, Ph.D., Memorial Sloan-Kettering Cancer Institute, New York, N.Y.
Hsp90-targeted Therapy for Small Cell Lung Cancer
AACR-Pennsylvania Department of Health Career Development Award in Cancer Research
Katherine L. Pogue-Geile, Ph.D., University of Pittsburgh, Pittsburgh, Pa.
Functional Identification of Pancreatic Cancer Tumor Suppressor Genes
AACR-California Department of Health Services Career Development Award in Ovarian Cancer Research
Andrew J. Li, M.D., Cedars-Sinai Medical Center & David Geffen School of Medicine at UCLA, Los Angeles, Calif.
Androgen Receptor Polymorphisms Modulate TGF-beta Signaling in Ovarian Cancer Biology
AACR-California Department of Health Services Career Development Award in Prostate Cancer Research
Anjali Jain, Ph.D., Cedars-Sinai Prostate Cancer Center & University of California, Los Angeles
HER-kinase Axis Directed Therapy of Androgen Independent Prostate Cancer
AACR Career Development Awards were first established in 1999 to provide important transitional support for direct research expenses as researchers move from the ranks of early career scientists to faculty status. Each award provides a two-year grant of $50,000 per year. Through this program, the AACR has distributed approximately $1 million in research funding.
Research Fellowships
AACR-Amgen, Inc. Fellowships in Clinical or Translational Cancer Research
Alice E. Guardino, M.D., Ph.D., Stanford University, Stanford, Calif.
Turning Lymphoma Cells into a Tumor Vaccine
John V. Heymach, M.D., Ph.D., Children's Hospital, Boston and Dana-Farber Cancer Institute, Boston, Mass.
Circulating Endothelial Cells as a Surrogate Marker of Anti-angiogenic Activity in Lung Cancer: Preclinical and Clinical Studies
AACR-Anna D. Barker Fellowship in Basic Cancer Research
Geneviève Rodier, Ph.D., Institut de Recherches Cliniques de Montréal, Montréal, Quebec, Canada
Regulation of the SKP2 Protooncogene by Phosphorylation
AACR-Bristol-Myers Squibb Oncology Fellowship in Clinical Cancer Research
David Z. Chang, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center, New York, N.Y.
Xenogeneic gp100 DNA Vaccination to Break Immune Tolerance: A Phase I Trial to Assess Safety and Immune Responses in AJCC Stage IIB, IIC, III, and IV Melanoma Patients
AACR-Pennsylvania Department of Health Fellowship in Cancer Research
Cameron N. Johnstone, Ph.D., University of Pennsylvania, Philadelphia, Pa.
Identification and Characterization of Candidate Tumor Suppressor Genes for Colorectal and Breast Cancer on Chromosome 22q
AACR-Cancer Research and Prevention Foundation Fellowship in Cancer Prevention Research
Zhongxing Liang, M.D., Ph.D., Emory University, Atlanta, Ga.
Prevention of Breast Cancer Metastasis by Using CXCR4 Antagonists
AACR-Cancer Research and Prevention Foundation Fellowship in Translational Lung Cancer Research
Patrick C. Ma, M.D., Dana-Farber Cancer Institute, Boston, Mass.
c-Met Mutational and Functional Analysis in Small Cell Lung Cancer: Potential for Therapeutic Inhibition
The AACR Research Fellowships in basic, translational, clinical, and prevention research were established in 1996 in response to the growing need for additional funds to train early career scientists throughout the world. The fellowships are one-, two-, and three-year grants in the amount of $30,000 per year. To date, the AACR has distributed over $1.5 million in research funding through this program.
Founded in 1907, the American Association for Cancer Research (AACR) is a professional society of more than 20,000 laboratory and clinical scientists engaged in cancer research in the United States and more than 60 other countries. AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals (Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention). AACR's annual meeting attracts more than 15,000 participants who share new and significant discoveries in the cancer field, and the AACR's specialty meetings throughout the year focus on all the important areas of basic, translational and clinical cancer research.